Federal Register / Vol. 85, No. 250 / Wednesday, December 30, 2020 / Notices 86567 

FEDERAL RESERVE SYSTEM 

Notice of Proposals To Engage in or 

To Acquire Companies Engaged in 

Permissible Nonbanking Activities 

The companies listed in this notice 

have given notice under section 4 of the 

Bank Holding Company Act (12 U.S.C. 

1843) (BHC Act) and Regulation Y, (12 

CFR part 225) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors, 

Ann E. Misback, Secretary of the Board, 

20th Street and Constitution Avenue 

NW, Washington, DC 20551–0001, not 

later than January 29, 2021. 

A. Federal Reserve Bank of Atlanta 

(Kathryn Haney, Assistant Vice 

President) 1000 Peachtree Street NE, 

Atlanta, Georgia 30309. Comments can 

also be sent electronically to 

Applications.Comments@atl.frb.org: 

1. FirstBanc of Alabama, Inc., 

Talladega, Alabama; to acquire 

SouthFirst Bank, Sylacauga, Alabama, 

and thereby engage in operating a 

savings association pursuant to 

§ 225.28(b)(4)(ii) of Regulation Y. 

B. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. Marathon Bancorp, Inc., Wausau, 

Wisconsin; to make a loan to Marathon 

Bank Employee Stock Ownership Plan 

located in Wausau, Wisconsin, and 

thereby engage in extending credit and 

servicing loans pursuant to 

§ 225.28(b)(1) of Regulation Y. 

Board of Governors of the Federal Reserve 

System, December 23, 2020. 

Margaret McCloskey Shanks, 

Deputy Secretary of the Board. 

[FR Doc. 2020–28862 Filed 12–29–20; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers CMS–10650 and 

CMS–10715] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

March 1, 2021. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number lll, Room C4–26– 

05, 7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing.html. 

2. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10650—State Permissions for 

Enrollment in Qualified Health Plans 

in the Federally-Facilitated Exchange 

& Non-Exchange Entities 

CMS–10715—Transparency in Coverage 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

86568 Federal Register / Vol. 85, No. 250 / Wednesday, December 30, 2020 / Notices 

Information Collection: State 

Permissions for Enrollment in Qualified 

Health Plans in the Federally-Facilitated 

Exchange & Non-Exchange Entities; Use: 

On March 23, 2010, the Patient 

Protection and Affordable Care Act 

(PPACA; Pub. L. 111–148) was signed 

into law and on March 30, 2010, the 

Health Care and Education 

Reconciliation Act of 2010 (Pub. L. 111– 

152) was signed into law. The two laws 

implement various health insurance 

policies. 

This information collection request 

(ICR) serves as the renewal of the data 

collection clearance related to the 

ability of states to permit agents and 

brokers, as well as Web-brokers, to assist 

qualified individuals, qualified 

employers, or qualified employees 

enrolling in Qualified Health Plans in 

the Federally Facilitated Exchange (45 

CFR 155.220) and data collection 

requirements related to non-exchange 

entities. (45 CFR 155.260). [All 

references to § 155.220 shall mean 45 

CFR 155.220.] Form Number: CMS– 

10650; Frequency: Annually; Affected 

Public: Private Sector, State, Business, 

and Not-for Profits; Number of 

Respondents: 55,148; Number of 

Responses: 55,148; Total Annual Hours: 

272,707. (For questions regarding this 

collection, contact Michele Oshman at 

(301–492–4407). 

2. Type of Information Collection 

Request: New collection (Request for a 

new OMB control number); Title of 

Information Collection: Transparency in 

Coverage; Use: The final rules titled 

‘‘Transparency in Coverage,’’ published 

November 12, 2020 (85 FR 72158), 

establish requirements for group health 

plans and health insurance issuers 

offering non-grandfathered coverage in 

the individual and group markets to 

disclose to a participant, beneficiary, or 

enrollee (or an authorized representative 

on behalf of such individual) the 

consumer-specific estimated costsharing liability for covered items or 

services from a particular provider, 

thereby allowing a participant, 

beneficiary, or enrollee to obtain an 

accurate estimate and understanding of 

their potential out-of-pocket expenses 

and to effectively shop for covered items 

and services. Plans and issuers are 

required to make such information 

available for covered items and services 

through an internet-based self-service 

tool, and, if requested, in paper form. 

The internet-based self-service tool must 

allow participants, beneficiaries, or 

enrollees to search for cost-sharing 

information for a covered item or 

service by inputting the name of a 

specific in-network provider in 

conjunction with a billing code or 

descriptive term, as well as other 

relevant factors such as location of 

service, facility name, or dosage. In 

addition, the final rules require that the 

tool allow the user to refine and reorder 

search results based on geographic 

proximity of in-network providers. For 

covered items and services provided by 

out-of-network providers, the tool must 

provide the out-of-network allowed 

amount, percentage of billed charges, or 

other rates that provide a reasonably 

accurate estimate of the amount a plan 

or issuer will pay by allowing 

consumers to input a billing code, 

descriptive code, or other relevant 

factor, such as location. 

The final rules also require plans and 

issuers to publicly disclose applicable 

rates with in-network providers, 

including negotiated rates; historical 

data outlining the different billed 

charges and allowed amounts a plan or 

issuer has paid for covered items or 

services, including prescription drugs, 

furnished by out-of-network providers; 

and negotiated rates and historical net 

prices for covered prescription drugs 

furnished by in-network providers 

through three machine-readable files (an 

In-network Rate File, Allowed Amount 

File, and Prescription Drug File). The 

machine-readable files must be posted 

publicly on an internet website and 

updated on a monthly basis. Form 

Number: CMS–10715 (OMB control 

number 0938–1372); Frequency: 

Frequently; Affected Public: Public and 

Private sectors; Number of Respondents: 

908; Total Annual Responses: 74,460; 

Total Annual Hours: 28,618,546. (For 

policy questions regarding this 

collection contact Russell Tipps at 301– 

492–4371). 

Dated: December 23, 2020. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2020–28851 Filed 12–29–20; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

Statement of Organization, Functions, 

and Delegations of Authority 

Part F of the Statement of 

Organization, Functions, and 

Delegations of Authority for the 

Department of Health and Human 

Services, Centers for Medicare & 

Medicaid Services (CMS) (last amended 

at 75 FR 14176–14178, dated March 24, 

2010), is republished to realign 

functions in the Center for Program 

Integrity (CPI). 

CPI is the focal point for all national 

and State-wide Medicare and Medicaid 

programs and integrity fraud and abuse 

issues related to the Children’s Health 

Insurance Program (CHIP). It promotes 

the integrity of the Medicare and 

Medicaid programs and CHIP through 

provider/contractor audits, policy 

reviews, identification and monitoring 

of program vulnerabilities, and provides 

support and technical assistance to 

States. In addition, it recommends 

modifications to programs and 

operations as necessary and works with 

CMS Centers, Offices, and the Chief 

Operating Officer to affect changes as 

appropriate, and collaborates with the 

Office of Legislation on the 

development and advancement of new 

legislative initiatives and improvements 

to deter, reduce, and eliminate fraud, 

waste and abuse. 

Part F, Section FC. 20 (Functions) is 

as follows: 

Center for Program Integrity 

• Serves as CMS’ focal point for all 

national and State-wide Medicare and 

Medicaid programs and CHIP integrity 

fraud and abuse issues. 

• Promotes the integrity of the 

Medicare and Medicaid programs and 

CHIP through provider/contractor audits 

and policy reviews, identification and 

monitoring of program vulnerabilities, 

and providing support and assistance to 

States. Recommends modifications to 

programs and operations as necessary 

and works with CMS Centers, Offices, 

and the Chief Operating Officer (COO) 

to affect changes as appropriate. 

Collaborates with the Office of 

Legislation on the development and 

advancement of new legislative 

initiatives and improvements to deter, 

reduce, and eliminate fraud, waste and 

abuse. 

• Oversees all CMS interactions and 

collaboration with key stakeholders 

relating to program integrity (i.e., U.S. 

Department of Justice, DHHS Office of 

Inspector General, State law 

enforcement agencies, other Federal 

entities, CMS components) for the 

purposes of detecting, deterring, 

monitoring and combating fraud and 

abuse, as well as taking action against 

those that commit or participate in 

fraudulent or other unlawful activities. 

• In collaboration with other CMS 

Centers, Offices, and the COO, develops 

and implements a comprehensive 

strategic plan, objectives and measures 

to carry out CMS’ Medicare, Medicaid 

and CHIP program integrity mission and 

goals, and ensure program